Endoluminal device for in vivo delivery of bioactive agents
US10327925B2 · kind B2 · utility
0Cited by
68References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 9, 2014 |
| Grant date | Jun 25, 2019 |
| Priority date | — |
| Expiry date | Apr 9, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F2250/0068
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present invention consists of an implantable structural element for in vivo delivery of bioactive active agents to a situs in a body. The implantable structural element may be configured as an implantable prosthesis, such as an endoluminal stent, cardiac valve, osteal implant or the like, which serves a dual function of being prosthetic and a carrier for a bioactive agent. Alternatively, the implantable structural element may simply be an implantable article that serves the single function of acting as a time-release carrier for the bioactive agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.